Omica Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Omica General Information

Description

Developer of a medical technology designed to develop artificial intelligence tools to improve cancer care in Latin America. The company's technology specializes in analyzing the genetic code of both biological parents to mitigate possible risks associated with congenital diseases, infertility, or pregnancy complications and also helps with identifying hereditary cancer in females, enabling patients to get forward-thinking bioethical standards.

Contact Information

Website
www.omica.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 184 Kent Avenue
  • Brooklyn
  • New York, NY 11249
  • United States
+1 (557)
Primary Industry
Other Healthcare Technology Systems
Corporate Office
  • 184 Kent Avenue
  • Brooklyn
  • New York, NY 11249
  • United States
+1 (557)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 10-Dec-2024 Completed Startup
3. Seed Round 16-Feb-2024 Completed Startup
2. Seed Round 01-Oct-2022 Completed Startup
1. Accelerator/Incubator 08-Jun-2021 Completed Startup
To view Omica’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Omica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Omica Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
PharmStars Accelerator/Incubator
Mucker Capital Venture Capital Minority
Plug and Play Accelerator/Incubator Minority
Axial (San Francisco) Venture Capital Minority
Caffeinated Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Omica Investments (1)

Omica’s most recent deal was a Seed Round with Genobank.io. The deal was made on 31-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Genobank.io 31-Oct-2022 Seed Round Other Devices and Supplies
To view Omica’s complete investments history, request access »

Omica FAQs

  • When was Omica founded?

    Omica was founded in 2021.

  • Where is Omica headquartered?

    Omica is headquartered in New York, NY.

  • What is the size of Omica?

    Omica has 8 total employees.

  • What industry is Omica in?

    Omica’s primary industry is Other Healthcare Technology Systems.

  • Is Omica a private or public company?

    Omica is a Private company.

  • What is Omica’s current revenue?

    The current revenue for Omica is .

  • Who are Omica’s investors?

    PharmStars, Mucker Capital, Plug and Play, Axial (San Francisco), and Caffeinated Capital are 5 of 6 investors who have invested in Omica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process